Personalized Genomics for Symptom Management: Bridging the Gaps from Genomic Discovery to Improved Health Outcomes (R21)

Post Date

January 11th 2011

Application Due Date

April 18th 2011

Funding Opportunity Number

RFA-NR-11-004

CFDA Number(s)

93.361

Funding Instrument Type(s)

Grant

Funding Activity Categories

Education
Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Award Range:

  $None - $200000

Grant Description

The National Institute of Nursing Research (NINR) seeks to stimulate research that will link basic genomic discovery to the prevention and alleviation of symptoms in patients suffering from chronic disorders. Research grant applications are requested to study 1) the role of genomic variants in the observed inter-individual variation in the onset, sensitivity, duration, and severity of symptoms and/or responses to therapies designed to prevent, alleviate, or eliminate symptoms, and 2) the role of non-genomic influence(s) that may potentially moderate the effects of genomic variants in the manifestation of symptoms and/ or response to treatment. It is anticipated that the findings from this research will expand the body of knowledge needed to identify individuals at the highest risk for developing severe symptoms and to inform the search for customized therapeutics and interventions tailored to an individuals genomic profile.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-NR-11-004.html